|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"lu sn"
Showing items 1-25 of 34 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2022-12-31 |
Secular trends of clinical characteristics and survival of hepatocellular carcinoma in Taiwan from 2011 to 2019
|
Kee, KM;Chen, CH;Hu, JT;Huang, YH;Wang, TE;Chau, GY;Chen, KH;Chen, YL;Lin, CC;Hung, CF;Huang, SF;Liu, TW;Ku, HY;Huang, BS;Wang, YP;Tseng, HP;Chiang, CJ;Lu, SN |
| 國家衛生研究院 |
2022-01-14 |
Serum soluble programmed cell death 1 levels predict spontaneous functional cure in inactive carriers with chronic hepatitis B
|
Hu, HH;Jeng, WJ;Pan, MH;Luo, WS;Chang, CL;Huang, YT;Su, CY;Chiang, CT;Jen, CL;Chien, YC;Lu, SN;Wang, LY;Huang, LR;Lee, MH;Liu, J;Nguyen, MH;Chen, CJ;Yang, HI |
| 國家衛生研究院 |
2021-07-15 |
How may ramucirumab help improve treatment outcome for patients with gastrointestinal cancers?
|
Chen, MH;Lu, SN;Chen, CH;Lin, PC;Jiang, JK;D'Yachkova, Y;Lukanowski, M;Cheng, R;Chen, LT |
| 國家衛生研究院 |
2020-03 |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: A TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
|
Chen, LT;Martinelli, E;Cheng, AL;Pentheroudakis, G;Qin, S;Bhattacharyya, GS;Ikeda, M;Lim, HY;Ho, GF;Choo, SP;Ren, Z;Malhotra, H;Ueno, M;Ryoo, BY;Kiang, TC;Tai, D;Vogel, A;Cervantes, A;Lu, SN;Yen, CJ;Huang, YH;Chen, SC;Hsu, C;Shen, YC;Tabernero, J;Yen, Y;Hsu, CH;Yoshino, T;Douillard, JY |
| 國家衛生研究院 |
2018-04-05 |
ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma
|
Abou-Alfa, G;Qin, S;Ryoo, BY;Lu, SN;Yen, CJ;Feng, YH;Lim, HY;Izzo, F;Colombo, M;Sarker, D;Bolondi, L;Vaccaro, G;Harris, WP;Chen, Z;Hubner, RA;Meyer, T;Sun, W;Harding, JJ;Hollywood, EM;Ma, J;Wan, PJ;Ly, M;Bomalaski, J;Johnston, A;Lin, CC;Chao, Y;Chen, LT |
| 國家衛生研究院 |
2017-10 |
Serum soluble programmed cell death 1 level as a key predictor for spontaneous functional cure of chronic hepatitis B patients
|
Hu, HH;Pan, MH;Luo, WS;Chang, CL;Jeng, RWJ;Huang, YT;Su, CY;Chiang, CT;Jen, CL;Lu, SN;Wang, LY;Huang, LR;Shih, CH;Chen, CJ;Yang, HI |
| 國家衛生研究院 |
2016-05 |
Phase III randomized study of second line ADI-peg 20 (A) plus best supportive care versus placebo (P) plus best supportive care in patients (pts) with advanced hepatocellular carcinoma (HCC)
|
Abou-Alfa, GK;Qin, SK;Ryoo, BY;Lu, SN;Yen, CJ;Feng, YH;Lim, HY;Izzo, F;Colombo, M;Sarker, D;Bolondi, L;Vaccaro, GM;Harris, WP;Chen, ZD;Hubner, R;Meyer, T;Bomalaski, JS;Lin, CC;Chao, Y;Chen, LT |
| 中國醫藥大學 |
2014-03 |
A double-blind randomized controlled study to evaluate the efficacy of low-dose oral interferon-alpha in preventing hepatitis C relapse
|
(Lee CM);(Chen CY);(Chien RN);(Tseng KC);彭成元(Cheng-Yuan Peng);(Tung SY);(Fang YJ);(Huang YH);(Lu SN);(Hung CH);(Tsai TJ);(Fang CC);(Hsu CW);(Yeh CT)* |
| 中國醫藥大學 |
2013-03 |
Prediction models of long-term cirrhosis and HCC risk in chronic hepatitis B patients: Risk scores integrating host and virus profiles
|
(Lee MH);楊懷壹(Hwai-I Yang);(Liu J);(Batrla-Utermann R);(Jen CL);(Iloeje UH);(Lu SN);(You SL);(Wang LY);(Chen CJ)* |
| 高雄醫學大學 |
2013 |
Sustained hcv clearance and increased HBsAg seroclearance in patients with dual chronic hepatitis C and B during post-treatment follow-up.
|
余明隆;李詮謀;Chen, CL;莊萬龍;盧勝男;劉振樺;Wu, SS;廖麗瑛;郭行道;趙有誠;董水義;楊賢馨;高嘉宏;Su, WW;Lin, CL;Yang, HC;陳培哲;陳定信;劉俊人*;Taiwan Liver-Net, Consortium. ; Yu, ML;Lee, CM;Chen, CL;Chuang, WL;Lu, SN;Liu, CH;Wu, SS;Liao, LY;Kuo, HT;Chao, YC;Tung, SY;Yang, SS;Kao, JH;Su, WW;Lin, CL;Yang, HC;Chen, PJ;Chen, DS;Liu, CJ;Taiwan Liver-Net, Consortium. |
| 中國醫藥大學 |
2012-12 |
A Predictive Scoring System for the Seroclearance of HBsAg in HBeAg-seronegative Chronic Hepatitis B Patients with Genotype B or C Infection
|
(Liu J);(Lee MH);(Batrla-Utermann R);(Jen CL);(Iloeje UH);(Lu SN);(Wang LY);(You SL);(Hsiao CK);楊懷壹(Hwai-I Yang);(Chen CJ)* |
| 中國醫藥大學 |
2012-08 |
Chronic Hepatitis C Virus Infection Increases Mortality From Hepatic and Extrahepatic Diseases: A Community-Based Long-Term Prospective Study
|
(Lee MH);楊懷壹(Hwai-I Yang);(Lu SN);(Jen CL);(You SL);(Wang LY);(Wang CH);(Chen WJ);(Chen CJ)* |
| 中國醫藥大學 |
2012-04 |
Association between obesity, hypertriglyceridemia and low hepatitis B viral load
|
(Chiang CH);楊懷壹(Hwai-I Yang);(Jen CL);(Lu SN);(Wang LY);(You SL);(Su J);(Iloeje UH);(Chen CJ)* |
| 臺北醫學大學 |
2012 |
A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis C after sustained response to pegylated interferon and ribavirin combination therapy
|
Chang, KC;Hung, CH;Lu, SN;Wang, JH;LEE, CM;Chen, CH;Yen, MF;Lin, SC;Yen, YH;Tsai, MC;Tseng, PL;Hu, TH |
| 中國醫藥大學 |
2011-11-08 |
Single nucleotide polymorphisms associatiedwith elevated serum viral load of hepatitis B virus in patients with chronic hepatitis B: A genome-wide assoiation study in Taiwan
|
(Lee MH);楊懷壹(Hwai-I Yang);(Lin YJ);(Jen CL);(Lu SN);(Yuan Y)(Litalian ;G);(Chen CJ) |
| 中國醫藥大學 |
2011-09 |
Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C
|
(Huang YT);(Jen CL);楊懷壹(Hwai-I Yang);(Lee MH);(Su J);(Lu SN);(Iloeje UH);(Chen CJ)* |
| 中國醫藥大學 |
2011-06 |
Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma
|
(Chen CF);(Lee WC);楊懷壹(Hwai-I Yang);(Chang HC);(Jen CL);(Iloeje UH);(Su J);(Hsiao CK);(Wang LY);(You SL);(Lu SN);(Chen CJ)* |
| 高雄醫學大學 |
2011 |
A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients.
|
盧勝男;趙毅;王蒼恩;陳信成;彭康嘉康;陳培哲;陳立宗 ; Yang TS;Lu SN;Chao Y;Sheen IS;Lin CC;Wang TE;Chen SC;Wang JH;Liao LY;Thomson JA;Wang-Peng J;Chen PJ;Chen LT. |
| 高雄醫學大學 |
2011 |
Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses.
|
葉明倫;黃志富;劉俊人;李詮謀;戴嘉言;王景弘;林子堯;盧勝男;胡崇輝;余明隆;高嘉宏;莊萬龍;陳培哲;陳定信 ; Yeh ML;Hung CH;Huang JF;Liu CJ;Lee CM;Dai CY;Wang JH;Lin ZY;Lu SN;Hu TH;Yu ML;Kao JH;Chuang WL;Chen PJ;Chen DS. |
| 國家衛生研究院 |
2010-09 |
A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients
|
Yang, TS;Lu, SN;Chao, Y;Sheen, IS;Lin, CC;Wang, TE;Chen, SC;Wang, JH;Liao, LY;Thomson, JA;Wang-Peng, J;Chen, PJ;Chen, LT |
| 高雄醫學大學 |
2010 |
流行地區的B、C型肝炎與慢行腎臟病相關性--一個橫斷性研究
|
李佳蓉;林明彥;楊奕馨;盧勝男;陳鴻鈞;黃尚志; Lee JJ;Lin MY;Yang YH;Lu SN;Chen HC;Hwang SJ |
| 高雄醫學大學 |
2010 |
HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.
|
余明隆;李詮謀;莊萬龍;盧勝男;戴嘉言;黃志富;林子堯;胡琮輝;陳建宏;洪肇宏;王景弘;高嘉宏;賴明陽;劉振驊;蘇東弘;廖麗瑛;郭行道;趙有誠;董水義;楊賢馨;陳培哲;劉俊人;陳定信 ; Yu ML;Lee CM;Chuang WL;Lu SN;Dai CY;Huang JF;Lin ZY;Hu TH;Chen CH;Hung CH;Wang JH;Chen CL;Kao JH;Lai MY;Liu CH;Su TH;Wu SS;Liao LY;Kuo HT;Chao YC;Tung SY;Yang SS;Chen PJ;Liu CJ;Chen DS. |
| 高雄醫學大學 |
2009 |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
|
劉俊人;莊萬龍;李全謨;余明隆;盧勝男;吳順生;廖麗瑛;陳祈玲;郭行道;趙有誠;董水義;楊賢馨;高嘉宏;蘇維文;鄭永銘;陳培哲;陳定信 ; Liu CJ;Chuang WL;Lee CM;Yu ML;Lu SN;Wu SS;Liao LY;Chen CL;Kuo HT;Chao YC;Tung SY;Yang SS;Kao JH;Liu CH;Su WW;Lin CL;Jeng YM;Chen PJ;Chen DS |
| 國立臺灣大學 |
2008-12 |
Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.
|
Yang, WI; Yeh; SH, Chen, PJ; Iloeje, UH; Jen, CL; Su, J; Wang, LY; Lu, SN; You, SL; Chen, DS; Liaw, YF; Chen, CJ |
| 國立臺灣大學 |
2008-11 |
Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: A follow-up study in Taiwan
|
Chen, CL; Yang, HI; Yang, WS; Liu, CJ; Chen, PJ; You, SL; Wang, LY; Sun, CA; Lu, SN; Chen, DS; Chen, CJ |
Showing items 1-25 of 34 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page
|
